Vyloy

Active Ingredient(s): Zolbetuximab-clzb
FDA Approved: * October 18, 2024
Pharm Company: * ASTELLAS
Category: Cancer
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Vyloy 20 mg/ml Intravenous Injection, Powder, for Suspension
NDC: 0469-3425
Labeler:
Astellas Pharma Us, Inc.
Vyloy 20 mg/ml Intravenous Injection, Powder, for Suspension
NDC: 0469-4425
Labeler:
Astellas Pharma Us, Inc.